D.C. Circuit Stays Juul’s Challenge To E-Cigs Ban As FDA Begins New Review
WASHINGTON, D.C. — A District of Columbia Circuit U.S. Court of Appeals panel on July 7 granted a joint motion by Juul Labs Inc. (JLI) and the Food and Drug Administration...To view the full article, register now.
Already a subscriber? Click here to view full article